Mirati's KRAS-blocking cancer drug approved by FDA
BioPharma
Source: biopharmadive.com
Page 4 - Charles Baum News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Charles Baum. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Charles Baum Today - Breaking & Trending Today
Why Shares of Mirati Therapeutics Fell Tuesday
Investors and analysts were unimpressed by trial results on the company's combination therapy to treat non-small cell lung cancer.
Source: fool.com
Mirati Therapeutics Announces Update for the Phase 3 SAPPHIRE Study
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced that based on the results of an interim...
Source: prnewswire.com
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...
Source: prnewswire.com
Mirati Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Updates
/PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results for the third quarter of...
Source: prnewswire.com